Saira Amjed, MD

NPI 1871052019ActiveIndividual· Internal Medicine· New Orleans, LA

Internal Medicine (MD) in New Orleans, Louisiana, trained at Louisiana State University School of Medicine in New Orleans (class of 2019). Their prescriptions cost Medicare Part D more than their services did: $273,184 for 3,674 claims, against $9,758 paid for services in 2024. Novo Nordisk Inc reported $20.33 in payments in 2025, mostly food and beverage.

Overview

NPI	1871052019
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Mar 18, 2019
Last updated in NPPES	Dec 15, 2022
Certified by provider	Dec 15, 2022

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine Primary	207R00000X	330352	LA
Student in an Organized Health Care Education/Training Program	390200000X	—	—

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Internal Medicine (LA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	76
Services billed	150 across 16 procedure codes
Paid by Medicare	$9,758

Part D prescriptions in 2024

Prescriptions (claims)	3,674 · 8,512 30-day fills
Patients	358
Total drug cost	$273,184
Generic share	87% of claims

Medicare sources and data years

Education and affiliations

Medical school	Louisiana State University School of Medicine in New Orleans
Graduation year	2019
Medicare specialty	Internal Medicine
Telehealth	Offers telehealth